20
Ranbaxy Laboratories Limited Gurgaon In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Pravastatin sodium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-230 - Rev 00
This Chemical Type CEP, issued on December 14, 2009, remains in force until March 20, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 2059 associated with this CEP further emphasizes